Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-25-103621
Filing Date
2025-10-29
Accepted
2025-10-29 11:11:05
Documents
2
Period of Report
2025-10-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2529569d1_6k.htm 6-K 12274
2 EXHIBIT 99.1 tm2529569d1_ex99-1.htm EX-99.1 43213
  Complete submission text file 0001104659-25-103621.txt   56812
Mailing Address INDUSTRIEPARK ZWIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE GHENT Belgium
Business Address INDUSTRIEPARK ZWIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE GHENT Belgium 32 (9) 310 34 00
ARGENX SE (Filer) CIK: 0001697862 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38097 | Film No.: 251428170
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)